We are happy to announce that JETA Molecular celebrates 6th anniversary today. We thank to our partners, collaborators and customers for helping us to advance excellence in molecular diagnostics!
Read MoreThe HoloGRAFT™ kit, developed by JETA Molecular in cooperation with Omixon, detects cell-free, donor-derived circulating DNA as a biomarker of organ health after transplantation using the highly sensitive digital PCR (dPCR) technology. On April 11, 2022, the dPCR experts from JETA Molecular organized the World´s first demo at Children´s Hospital of Philadelphia (CHOP), US, using the QIAcuity Digital PCR System.
Read MoreJETA Molecular is proud to announce its new collaboration with VH Bio Ltd, for our DigitalTRACE dPCR Stem Cell Monitoring Kits and Software.
Read MoreThe recently published study by the team of Dr. J. Verhoeven from UMC Rotterdam uses the panel of DigitalTRACE™ Assays to investigate the diagnostic value of donor-derived cell-free DNA (dd-cfDNA) for the detection of acute kidney transplant rejection.
Read MoreWe are proud to announce that we have recently developed six new HLA assays, targeting allele subgroup A and C from the Class I HLA group. The new assays will be a welcome addition to our increasingly popular HLA TRACE™ panel, extending the number of HLA assays available to our customers to 28.
Read More+31 654 136 697 ⎜ info@jetabv.com
Krommewetering 101C, Utrecht, 3543AN, The Netherlands
Copyright © JETA Molecular BV.
All Rights Reserved │Privacy Policy
